Abstract
Point-of-care testing (POCT) in pediatric primary care is essential for clinicians to make a timely and accurate diagnosis. The COVID-19 pandemic has highlighted the importance of timely and accurate testing strategies to correctly identify the etiology of upper and lower respiratory infections. Additionally, pediatric POCT continues to be important in rural and underserved communities where access to hospital laboratories may be less available. This chapter will focus on seven rapid tests: Group A streptococcus (GAS), influenza A & B, SARS-CoV-2 (COVID-19), human immunodeficiency virus (HIV), C-reactive protein (CRP), human chorionic gonadotropin (hCG), and hemoglobin A1c (HbA1c).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AAP. FAQs: Management of infants born to mothers with suspected or confirmed COVID-19. 2020 Retrieved on January 30, 2021, http://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/faqs-management-of-infants-born-to-covid-19-mothers/
Abbott. Taking COVID-19 testing to a new level | Abbott U.S. Retrieved January 20, 2021., https://www.abbott.com/BinaxNOW-Test-NAVICA-App.html
Afinion HbA1c. 2019. https://www.globalpointofcare.abbott/en/product-details/afinion-hba1c.html. Accessed 31 Jan 2021
Agrawal S, Reinert SE, Baird GL, Quintos JB. Comparing HbA1C by POC and HPLC. R I Med J. (2013). 2018;101:43–6.
Agus MS, Alexander JL, Wolfsdorf JI. Utility of immediate hemoglobin A1c in children with type I diabetes mellitus. Pediatr Diabetes. 2010;11(7):450–4.
Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr. 2007a;96:487–91.
Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr. 2007b;96(3):338–41.
Alcoba G, Keitel K, Maspoli V, Lacroix L, Manzano S, Gehri M, Tabin R, Gervaix A, Galetto-Lacour A. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR. Eur J Pediatr. 2017;176:815–24.
Althaus T, Greer RC, Swe MMM, Cohen J, Tun NN, Heaton J, Nedsuwan S, et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Glob Health. 2019;7(1):e119–31.
Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007;26(8):672–7.
Atteih S, Ratner J. Endocrinology. In: Kleinman K, McDaniel L, Molloy M, editors. Harriet lane handbook. 22nd ed. Philadelphia: Elsevier Health Sciences; 2020.
Babady NE, Dunn JJ, Madej R. CLIA-waived molecular influenza testing in the emergency department and outpatient settings. J Clin Virol. 2019;116:44–8.
Baird GS. The choosing wisely initiative and laboratory test stewardship. Diagnosi. 2019;6(1):15–23.
Betz D, Fane K. Human chorionic gonadotropin. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2020.
Broeckaert L, Challacombe L. Rapid point-of-care HIV testing: a review of the evidence. 2015. Retrieved January 31, 2021, https://www.catie.ca/en/pif/spring-2015/rapid-point-care-hiv-testing-review-evidence.
CDC. HIV testing for pregnant women and newborns. 2016. Retrieved on March 7, 2021, https://www.cdc.gov/stophivtogether/library/one-test-two-lives/fact-sheets/cdc-lsht-ottl-factsheet-hiv-testing-for-pregnant-women-and-newborns.pdf
CDC. Rapid influenza diagnostic tests (RIDTs). 2020a. Retrieved on January 21, 2021 https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm#:~:text=Rapid%20influenza%20diagnostic%20tests%20(RIDTs,of%20RIDTs%20are%20commercially%20available.
CDC. Overview of influenza testing methods. 2020b Retrieved on January 29, 2021, https://www.cdc.gov/flu/professionals/diagnosis/overview-testing-methods.htm
CDC. Table 3. Nucleic acid detection based tests. 2020c Retrieved on January 29, 2021, from https://www.cdc.gov/flu/professionals/diagnosis/table-nucleic-acid-detection.html
CDC. Options to reduce quarantine for contacts of persons with SARS-CoV-2. In: Centers for disease control and prevention; 2020d. https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-options-to-reduce-quarantine.html. Accessed 30 Jan 2021.
CDC. Labs. In: Centers for Disease Control and Prevention. 2020e Accessed January 20, 2021, https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html
CDC. Antibiotic use in the United States, 2017: progress and opportunities | Antibiotic Use | CDC. 2020f Accessed February 6, 2021, https://www.cdc.gov/antibiotic-use/stewardship-report/2017.html
CDC. Diagnostic tests: newer, improved HIV tests allow for earlier HIV detection. 2020g. Accessed March 5, 2021, https://www.cdc.gov/hiv/clinicians/screening/diagnostic-tests.html
CDC. Benefits of routine screening | screening for HIV | Clinicians | HIV | CDC. 2020h. Accessed Jan 31, 2021, from https://www.cdc.gov/hiv/clinicians/screening/benefits.html.
CDC. Advantages and disadvantages of FDA-approved HIV assays used for screening, by test category. 2020i. [pdf] https://www.cdc.gov/hiv/pdf/testing/hiv-tests-advantages-disadvantages_1.pdf Accessed 31 January 2021
CDC. About teen pregnancy. 2020j Accessed March 5, 2021, https://www.cdc.gov/teenpregnancy/about/index.htm#:~:text=In%202017%2C%20a%20total%20of,drop%20of%207%25%20from%202016.&text=Birth%20rates%20fell%2010%25%20for,women%20aged%2018%E2%80%9319%20years.
CDC. Healthcare workers. In: Centers for Disease Control and Prevention. Retrieved October 25, 2020, 2020k. https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html.
CDC. HIV and pregnant women, infants, and children. 2021. Retrieved on March 7, 2021, https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html
CDC. Quarantine and isolation. 2022. Retrieved 29 January 2022, from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/quarantine-isolation.html
Centor Score (Modified/McIsaac) for Strep Pharyngitis. In: MDCalc. https://www.mdcalc.com/centor-score-modified-mcisaac-strep-pharyngitis. Accessed 24 Jan 2021.
Christy A. COVID-19: a review for the pediatric neurologist. J Child Neurol. 2020;35(13):934–9.
Clark J, Rao LV. Retrospective analysis of point-of-care and laboratory-based hemoglobin A1c testing. J Appl Lab Med. 2017;1(5):502–9.
Cohen DM, Russo ME, Jaggi P, Kline J, Gluckman W, Parekh A. Multicenter clinical evaluation of the novel Alere i Strep A isothermal nucleic acid amplification test. J Clin Microbiol. 2015;53(7):2258–61.
Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016;7(7):CD010502.
Committee on Pediatric AIDS, Emmanuel PJ, Martinez J. Adolescents and HIV infection: the pediatrician's role in promoting routine testing. Pediatrics. 2011;128(5):1023–9.
COVID-19 Testing Guidance. Retrieved on January 29, 2021, from: http://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-testing-guidance
Crocker JB, Lynch SH, Guarino AJ, Lewandrowski K. The impact of point-of-care hemoglobin A1c testing on population health-based onsite testing adherence: a primary-care quality improvement study. J Diabetes Sci Technol. 2020; 1932296820972751
Cruz AT, Demmler-Harrison GJ, Caviness AC, Buffone GJ, Revell PA. Performance of a rapid influenza test in children during the H1N1 2009 Influenza A outbreak. Pediatrics. 2010;125:e645–50.
English E, Schaffert L, Lenters-Westra E. Point-of-care testing for HbA1c: clinical need and analytical quality. Retrieved January 31, 2020, from Clinical Laboratory Int. https://clinlabint.com/point-of-care-testing-for-hba1c-clinical-need-and-analytical-quality/.
FDA. In vitro diagnostics EUAs. 2021. Retrieved January 21, 2021, from https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-molecular.
FilmArray Respiratory Panel EZ | In-Clinic Diagnostic Testing Solution. In: BioFire Diagnostics. https://www.biofiredx.com/products/the-filmarray-panels/filmarray-respiratory-panel-ez/. Accessed 30 Jan 2021.
Fiore K. What are the most popular COVID-19 Tests? 2020 Retrieved January 31, 2021, https://www.medpagetoday.com/infectiousdisease/covid19/89348.
Fiore K. Is delta variant more severe in children. 2021. Retrieved August 15, 2021, https://www.medpagetoday.com/special-reports/exclusives/93979
Food and Drug Administration (FDA). COVID-19 test uses: FAQs on testing for SARS-CoV-2. 2021. Retrieved February 18, 2021, from https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/covid-19-test-uses-faqs-testing-sars-cov-2
Fox JW, Marcon MJ, Bonsu BK. Diagnosis of streptococcal pharyngitis by detection of Streptococcus pyogenes in posterior pharyngeal versus oral cavity specimens. J Clin Microbiol. 2006;44(7):2593–4.
Frazee BW, RodrÃguez-Hoces de la Guardia A, Alter H, Chen CG, Fuentes EL, et al. Accuracy and discomfort of different types of intranasal specimen collection methods for molecular influenza testing in emergency department patients. Ann Emerg Med. 2018;71:509–517.e1.
Furtado LV, Lehman CM, Thompson C, Grenache DG. Should the qualitative serum pregnancy test be considered obsolete? Am J Clin Pathol. 2012;137:194–202.
Hagan JF, Shaw JS, Duncan PM, editors. Bright futures: guidelines for health supervision of infants, children, and adolescents. 4th ed. Elk Grove Village, IL: Bright Futures/American Academy of Pediatrics; 2017.
Hansen G, Marino J, Wang ZX, Beavis KG, Rodrigo J, Labog K, et al. Clinical performance of the point-of-care cobas Liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study. J Clin Microbiol. 2021;59(2):e02811–20.
Hanson KE, Caliendo AM, Arias CA, Englund JA, Hayden MK, Lee MJ, Loeb M, Patel R, Altayar O, El Alayli A, Sultan S, Falck-Ytter Y, Lavergne V, Morgan RL, Murad MH, Bhimraj A, Mustafa RA. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing. Clin Infect Dis. 2020 Sep 12:ciaa1343. https://doi.org/10.1093/cid/ciaa1343. Epub ahead of print. PMID: 32918466; PMCID: PMC7543294.
Hanson KE, Caliendo AM, Arias CA, Hayden MK, et al. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing. Infectious Diseases Society of America 2020; Retrieved on April 25, 2021, https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/
Hornberger LL. Committee on adolescence. Diagnosis of pregnancy and providing options counseling for the adolescent patient. Pediatrics. 2017;140(3):e20172273.
Jenco M. AAP: Wear face coverings during most sports. AAP News. 2021. Retrieved February 15, 2021, https://www.healthychildren.org/English/health-issues/conditions/COVID-19/Pages/Why-Cloth-Face-Coverings-are-Needed-in-Youth-Sports-During-COVID-19.aspx
John R. Respiratory disorders. In: Maaks DL, Starr NB, Brady MA, Gaylord NM, Driessnack M, Duderstadt KG, editors. Burns’ pediatric primary care. 7th ed. St. Louis, MO: Elsevier, Inc; 2019.
Kalra MG, Higgins KE, Perez ED. Common questions about streptococcal pharyngitis. Am Fam Physician. 2016;94(1):24–31.
Keitel K, Kagoro F, Samaka J, et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): a randomized, controlled non-inferiority trial. PLoS Med. 2017;14:e1002411.
Keitel K, Lacroix L, Gervaix A. Point-of-care testing in pediatric infectious diseases. Pediatr Infect Dis J. 2018;37:108–10.
King JR, Hammarström L. Newborn screening for primary immunodeficiency diseases: history, current and future practice. J Clin Immunol. 2018;38(1):56–66.
Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: past, present, and future. J Clin Microbiol. 2017;55(8):2313–20.
Latifi N, Kriegel G, Herskovits AZ. Point-of-care urine pregnancy tests. JAMA. 2019;322:2336–7.
Lean WL, Arnup S, Danchin M, Steer AC. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014;134(4):771–81.
Lee JJ, Verbakel JY, Goyder CR, Ananthakumar T, Tan PS, Turner PJ, et al. The clinical utility of point-of-care tests for influenza in ambulatory care: a systematic review and meta-analysis. Clin Infect Dis. 2019;69:24–33.
Lee TG, Yu ST, So CH. Predictive value of C-reactive protein for the diagnosis of meningitis in febrile infants under 3 months of age in the emergency department. Yeungnam U J Med. 2020;37(2):106–11.
Mathur G, Mathur S. Antibody testing for COVID-19: can it be used as a screening tool in areas with Low prevalence? Am J Clin Pathol. 2020;154:1–3.
McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998;158:75–83.
Miceika BG, Vitous AS, Thompson KD. Detection of group A streptococcal antigen directly from throat swabs with a ten-minute latex agglutination test. J Clin Microbiol. 1985;21(3):467–9.
Moffet HH, Parker MM, Sarkar U, Schillinger D, Fernandez A, Adler NE, et al. Adherence to laboratory test requests by patients with diabetes: the Diabetes Study of Northern California (DISTANCE). Am J Manag Care. 2011;17(5):339–44.
Morgan M, Perez K, Cavanaugh M. Tips for COVID 19 specimen collection for pediatric patients. 2020. https://www.advocatehealth.com/covid-19-info/_assets/documents/ambulatory-physician-office/covid-19-specimen-collection-for-pediatric-patients.pdf. Accessed 30 Jan 2021.
Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;23(8):1041.
Nathan DM, Griffin A, Perez FM, Basque E, Do L, Steiner B. Accuracy of a point-of-care Hemoglobin A1c assay. J Diabetes Sci Technol. 2019;13:1149–53.
Nationwide Children’s. Comfort hold techniques 2016. Retrieved on January 29, 2021, https://www.nationwidechildrens.org/family-resources-education/health-wellness-and-safety-resources/helping-hands/comfort-hold-techniques.
Nichols JH, Alter D, Chen Y, Isbell TS, Jacobs E, Moore N, Shajani-Yi Z. AACC Guidance Document on Management of Point-of-Care Testing. J Appl Lab Med. 2020;5(4):762–87. https://doi.org/10.1093/jalm/jfaa059. PMID: 32496555.
Nichols JH. Point-of-care testing. Clin Lab Med. 2007;27:893–908.
NIH. Panel on antiretroviral therapy and medical management of children living with HIV. (2019) Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Retrieved January 31, 2021, http://aidsinfo.nih.gov/content- les/lvguidelines/pediatricguidelines.pdf
NIH. SARS-CoV-2 testing. In: COVID-19 treatment guidelines (2021). Retrieved January 29, 2021, https://www.covid19treatmentguidelines.nih.gov/overview/sars-cov-2-testing
O’Brien MJ, Sacks DB. Point-of-care hemoglobin A1c. JAMA. 2019;322:1404–5.
Pai NP, Wilkinson S, Deli-Houssein R, Vijh R, Vadnais C, Behlim T, et al. Barriers to implementation of rapid and point-of-care tests for human immunodeficiency virus infection. Point Care. 2015;14:81–7.
Park Y, Choe Y, Park O, Park S, Kim Y, Kim J, et al. Contact tracing during coronavirus disease outbreak, South Korea, 2020. Emerg Infect Dis. 2020;26(10):2465–8.
Patel K, Suh-Lailam BB. Implementation of point-of-care testing in a pediatric healthcare setting. Crit Rev Clin Lab Sci. 2019;56(4):239–46.
Patel NA. Pediatric COVID-19: systematic review of the literature. Am J Otolaryngol. 2020;41(5):102573.
Patton SR, Noser AE, Youngkin EM, Majidi S, Clements MA. Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset type 1 diabetes mellitus. Diabetes Technol Ther. 2019;21(7):379–84.
Pondaven-Letourmy S, Alvin F, Boumghit Y, Simon F. How to perform a nasopharyngeal swab in adults and children in the COVID-19 era. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:325–7.
Prince K, Omar F, Joolay Y. A comparison of point of care C-reactive protein test to standard C-reactive protein laboratory measurement in a neonatal intensive care unit setting. J Trop Pediatr. 2019;65:498–504.
Pritt BS, Patel R, Kim TJ, Thomson RB. Point-counterpoint: a nucleic acid amplification test for streptococcus pyogenes should replace antigen detection and culture for detection of bacterial pharyngitis. J Clin Microbiol. 2016;54(10):2413–9.
Roulliaud M, Pereira B, Cosme J, Mourgues C, Sarret C, Sapin V, et al. Evaluation of the capillary assay of C-reactive protein (CRP) through the length of consultation in pediatric emergencies and its economic impact. Ann Biol Clin (Paris). 2018;76:545–52.
Samuel L. Point-of-care testing in microbiology. Clin Lab Med. 2020;40(4):483–94.
Scott K. The labs no one inspects | AACC.org. Retrieved January 18, 2021., https://www.aacc.org/cln/articles/2019/janfeb/the-labs-no-one-inspects. Accessed 18 Jan 2021.
Shapiro DJ, Lindgren CE, Neuman MI, Fine AM. Viral features and testing for streptococcal pharyngitis. Pediatrics. 2017;139:e20163403.
Shephard A, Smith G, Aspley S, Schachtel BP. Randomised, double-blind, placebo-controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians’ prediction of ‘strep throat’. Int J Clin Pract. 2015;69:59–71.
Shulman AJ. Office rapid strep tests: state of the art. Contemp. Pediatr. 2015: Retrieved January 25, 2021, https://www.contemporarypediatrics.com/view/office-rapid-strep-tests-state-art.
Shulman AM. POC influenza testing: state of the art. Contemp Pediatr. 2016; Retrieved January 29, 2021, https://www.contemporarypediatrics.com/view/poc-influenza-testing-state-art
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86–102.
Spooner E, Govender K, Reddy T, Ramjee G, Mbadi N, Singh S, Coutsoudis A. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study. BMC Public Health. 2019;19:731.
Szablewski CM, Chang KT, Brown MM, Chu VT, Yousaf AR, Anyalechi N, et al. SARS-CoV-2 transmission and infection among attendees of an overnight Camp—Georgia, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(31):1023–5.
Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol. 2020;58(6):e00512–20.
Thompson TZ, McMullen AR. Group A streptococcus testing in pediatrics: the move to point-of-care molecular testing. J Clin Microbiol. 2020;58(6):e01494–19.
Tran NK, May L, Hall A, Bullen T, Waldman S, Rodrigo J, et al. LBP rapid combined flu A/B and SARS-CoV-2 RNA polymerase chain reaction testing for emergency and ambulatory care settings. Accessed January 29, 2020., https://health.ucdavis.edu/blog/lab-best-practice/rapid-combined-flu-ab-and-sars-cov-2-rna-polymerase-chain-reaction-testing-for-emergency-and-ambulatory-care-settings/2020/11
Tsai CM, Lin CR, Zhang H, Chiu IM, Cheng CY, Yu HR, Huang YH. Using machine learning to predict bacteremia in febrile children presented to the emergency department. Diagnostics. 2020;10(5):307.
Tsao Y-T, Tsai Y-H, Liao W-T, Shen C-J, Shen C-F, Cheng C-M. Differential markers of bacterial and viral infections in children for point-of-care testing. Trends Mol Med. 2020;26:1118–32.
United States Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Screening for HIV infection: US preventive services task force recommendation statement. JAMA. 2019;321(23):2326.
Van Hecke O, Raymond M, Lee JJ, Turner P, Goyder CR, Verbakel JY, Van den Bruel A, Hayward G. In-vitro diagnostic point-of-care tests in paediatric ambulatory care: a systematic review and meta-analysis. PLoS One. 2020;15(7):e0235605.
Westlake P. Procise CRP Assay Receives CE Mark. 2020. Available at: https://clpmag.com/diagnostic-technologies/clinical-chemistry/procise-crp-assay-receives-ce-mark/.
White CB, Bass JW, Yamada SM. Rapid latex agglutination compared with the throat culture for the detection of group a streptococcal infection. Pediatr Infect Dis. 1986;5(2):208–12.
Whitley HP, Yong EV, Rasinen C. Selecting an A1C point-of-care instrument. Diabetes Spectr. 2015;28:201–8.
Wilson E, Donovan CV, Campbell M, Chai T, Pittman K, Seña AC, et al. Multiple COVID-19 clusters on a University Campus—North Carolina, August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1416–8.
Acknowledgement Figures 5.1–5.7 were contributed by Lieselotte Elliehausen.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Stace, L.B. (2022). Point-of-Care Testing in Primary Care. In: John, R.M. (eds) Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-90642-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-90642-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-90641-2
Online ISBN: 978-3-030-90642-9
eBook Packages: MedicineMedicine (R0)